National Status: Getting worse
Most Recent Data:
14.3
deaths per 100,000 population
(2024) *
National Target:
8.9
per 100,000
*
Desired Direction:
Decrease desired
National Baseline:
9.9 deaths per 100,000 population were caused by an overdose involving synthetic opioids other than methadone in 2018 *
* Age adjusted to the year 2000 standard population.
View CI in the chart by hovering over a data point.
View SE in the chart by hovering over a data point.
Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available
Drug overdose deaths involving synthetic opioids, excluding methadone, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Total |
9.9 CI 9.8 / 10.0 SE 0.057 |
11.4 CI 11.3 / 11.5 SE 0.061 |
17.8 CI 17.6 / 17.9 SE 0.076 |
21.8 CI 21.7 / 22.0 SE 0.084 |
22.7 CI 22.5 / 22.9 SE 0.085 |
22.2 CI 22.0 / 22.3 SE 0.084 |
14.3 CI 14.2 / 14.4 SE 0.067 |
Drug overdose deaths involving synthetic opioids, excluding methadone by Sex, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Male |
14.2 CI 14.1 / 14.4 SE 0.097 |
16.6 CI 16.4 / 16.8 SE 0.104 |
25.9 CI 25.7 / 26.2 SE 0.130 |
31.4 CI 31.2 / 31.7 SE 0.141 |
32.9 CI 32.6 / 33.2 SE 0.144 |
32.4 CI 32.1 / 32.7 SE 0.143 |
20.6 CI 20.4 / 20.8 SE 0.113 |
Female |
5.5 CI 5.4 / 5.7 SE 0.060 |
6.3 CI 6.2 / 6.4 SE 0.064 |
9.6 CI 9.4 / 9.8 SE 0.079 |
12.2 CI 12.0 / 12.3 SE 0.089 |
12.4 CI 12.2 / 12.5 SE 0.089 |
11.9 CI 11.7 / 12.1 SE 0.087 |
8.0 CI 7.9 / 8.2 SE 0.071 |
Drug overdose deaths involving synthetic opioids, excluding methadone by Race/Ethnicity, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
American Indian or Alaska Native only |
4.4 CI 3.7 / 5.1 SE 0.330 |
6.7 CI 5.9 / 7.5 SE 0.404 |
13.4 CI 12.3 / 14.6 SE 0.570 |
20.9 CI 19.5 / 22.3 SE 0.706 |
26.7 CI 25.2 / 28.4 SE 0.801 |
28.5 CI 26.9 / 30.2 SE 0.821 |
19.3 CI 18.1 / 20.7 SE 0.661 |
Asian only |
0.9 CI 0.8 / 1.0 SE 0.066 |
1.1 CI 1.0 / 1.3 SE 0.073 |
2.3 CI 2.1 / 2.5 SE 0.105 |
2.4 CI 2.2 / 2.6 SE 0.106 |
3.0 CI 2.8 / 3.2 SE 0.117 |
3.1 CI 2.9 / 3.3 SE 0.118 |
2.1 CI 1.9 / 2.3 SE 0.093 |
Native Hawaiian or Other Pacific Islander only |
1.6 CI 0.8 / 3.0 SE 0.441 |
2.6 CI 1.6 / 4.1 SE 0.546 |
4.1 CI 2.9 / 5.9 SE 0.697 |
8.9 CI 7.0 / 11.3 SE 1.021 |
8.0 CI 6.2 / 10.2 SE 0.945 |
13.0 CI 10.8 / 15.7 SE 1.203 |
8.7 CI 6.9 / 10.9 SE 0.968 |
Black or African American only |
10.8 CI 10.5 / 11.1 SE 0.158 |
14.0 CI 13.7 / 14.4 SE 0.180 |
23.2 CI 22.8 / 23.7 SE 0.230 |
30.3 CI 29.8 / 30.8 SE 0.261 |
33.7 CI 33.2 / 34.3 SE 0.274 |
35.0 CI 34.5 / 35.6 SE 0.278 |
21.0 CI 20.6 / 21.4 SE 0.213 |
White only |
10.9 CI 10.8 / 11.1 SE 0.069 |
12.3 CI 12.2 / 12.5 SE 0.074 |
18.7 CI 18.5 / 18.9 SE 0.091 |
22.6 CI 22.4 / 22.8 SE 0.099 |
23.0 CI 22.8 / 23.2 SE 0.100 |
21.9 CI 21.7 / 22.1 SE 0.097 |
14.4 CI 14.3 / 14.6 SE 0.078 |
2 or more races |
3.6 CI 3.1 / 4.1 SE 0.232 |
4.7 CI 4.2 / 5.3 SE 0.264 |
9.2 CI 8.5 / 9.9 SE 0.361 |
12.0 CI 11.2 / 12.9 SE 0.411 |
13.5 CI 12.7 / 14.4 SE 0.428 |
15.2 CI 14.3 / 16.2 SE 0.457 |
10.5 CI 9.8 / 11.3 SE 0.373 |
Hispanic or Latino |
4.7 CI 4.5 / 4.9 SE 0.091 |
6.3 CI 6.1 / 6.5 SE 0.103 |
10.7 CI 10.4 / 10.9 SE 0.133 |
14.2 CI 13.9 / 14.5 SE 0.152 |
16.0 CI 15.7 / 16.4 SE 0.161 |
16.5 CI 16.2 / 16.8 SE 0.161 |
10.9 CI 10.6 / 11.1 SE 0.129 |
Not Hispanic or Latino |
11.1 CI 11.0 / 11.2 SE 0.067 |
12.6 CI 12.4 / 12.7 SE 0.072 |
19.4 CI 19.2 / 19.5 SE 0.089 |
23.5 CI 23.3 / 23.7 SE 0.097 |
24.1 CI 23.9 / 24.3 SE 0.098 |
23.3 CI 23.1 / 23.5 SE 0.096 |
15.0 CI 14.8 / 15.1 SE 0.077 |
American Indian or Alaska Native only, not Hispanic or Latino |
7.0 CI 6.0 / 8.2 SE 0.561 |
10.8 CI 9.4 / 12.2 SE 0.687 |
21.6 CI 19.7 / 23.6 SE 0.971 |
33.6 CI 31.3 / 36.0 SE 1.205 |
43.6 CI 41.0 / 46.5 SE 1.384 |
46.5 CI 43.8 / 49.4 SE 1.427 |
32.3 CI 30.0 / 34.7 SE 1.184 |
Asian only, not Hispanic or Latino |
0.9 CI 0.8 / 1.0 SE 0.066 |
1.1 CI 0.9 / 1.2 SE 0.072 |
2.2 CI 2.0 / 2.4 SE 0.106 |
2.2 CI 2.0 / 2.5 SE 0.105 |
2.8 CI 2.6 / 3.1 SE 0.116 |
3.0 CI 2.8 / 3.2 SE 0.118 |
2.0 CI 1.8 / 2.2 SE 0.092 |
Native Hawaiian or Other Pacific Islander only, not Hispanic or Latino |
DSU |
1.8 CI 0.9 / 3.4 SE 0.530 |
4.5 CI 3.0 / 6.6 SE 0.845 |
8.9 CI 6.8 / 11.7 SE 1.190 |
7.7 CI 5.7 / 10.3 SE 1.087 |
14.1 CI 11.4 / 17.4 SE 1.466 |
9.9 CI 7.6 / 12.6 SE 1.200 |
Black or African American only, not Hispanic or Latino |
11.2 CI 10.8 / 11.5 SE 0.166 |
14.4 CI 14.0 / 14.8 SE 0.188 |
24.1 CI 23.6 / 24.6 SE 0.243 |
31.4 CI 30.8 / 31.9 SE 0.274 |
34.7 CI 34.2 / 35.3 SE 0.288 |
36.1 CI 35.5 / 36.7 SE 0.292 |
21.5 CI 21.1 / 22.0 SE 0.223 |
White only, not Hispanic or Latino |
12.7 CI 12.6 / 12.9 SE 0.086 |
14.0 CI 13.8 / 14.2 SE 0.090 |
20.9 CI 20.7 / 21.1 SE 0.110 |
24.8 CI 24.6 / 25.1 SE 0.119 |
24.7 CI 24.5 / 25.0 SE 0.119 |
23.2 CI 23.0 / 23.4 SE 0.115 |
15.3 CI 15.1 / 15.4 SE 0.093 |
2 or more races, not Hispanic or Latino |
4.0 CI 3.5 / 4.6 SE 0.278 |
5.1 CI 4.5 / 5.8 SE 0.310 |
9.8 CI 9.0 / 10.7 SE 0.424 |
13.1 CI 12.2 / 14.1 SE 0.490 |
14.7 CI 13.7 / 15.7 SE 0.508 |
16.1 CI 15.1 / 17.2 SE 0.535 |
11.5 CI 10.6 / 12.4 SE 0.446 |
Drug overdose deaths involving synthetic opioids, excluding methadone by Age group, 2018-2024 †
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
<18 years |
0.1 CI 0.1 / 0.2 SE 0.014 |
0.2 CI 0.2 / 0.3 SE 0.018 |
0.6 CI 0.5 / 0.6 SE 0.028 |
0.8 CI 0.8 / 0.9 SE 0.034 |
1.0 CI 0.9 / 1.1 SE 0.037 |
1.1 CI 1.0 / 1.1 SE 0.038 |
0.5 CI 0.5 / 0.6 SE 0.027 |
0-4 years |
0.1 CI 0.1 / 0.1 SE 0.022 |
0.2 CI 0.1 / 0.3 SE 0.032 |
0.3 CI 0.2 / 0.4 SE 0.040 |
0.7 CI 0.6 / 0.8 SE 0.061 |
1.0 CI 0.8 / 1.1 SE 0.073 |
1.1 CI 1.0 / 1.3 SE 0.078 |
0.7 CI 0.6 / 0.9 SE 0.063 |
5-11 years |
DSU |
DSU |
DSU |
0.0 CI 0.0 / 0.1 SE 0.013 |
0.1 CI 0.0 / 0.1 SE 0.016 |
0.1 CI 0.0 / 0.1 SE 0.015 |
0.0 CI 0.0 / 0.1 SE 0.012 |
12-17 years |
0.3 CI 0.3 / 0.4 SE 0.036 |
0.5 CI 0.4 / 0.6 SE 0.045 |
1.4 CI 1.3 / 1.6 SE 0.075 |
1.8 CI 1.7 / 2.0 SE 0.084 |
2.0 CI 1.9 / 2.2 SE 0.089 |
2.1 CI 1.9 / 2.3 SE 0.089 |
1.0 CI 0.8 / 1.1 SE 0.060 |
18-44 years |
17.2 CI 17.0 / 17.4 SE 0.121 |
19.4 CI 19.2 / 19.7 SE 0.128 |
30.3 CI 30.0 / 30.6 SE 0.160 |
36.2 CI 35.9 / 36.6 SE 0.174 |
36.1 CI 35.8 / 36.5 SE 0.173 |
34.3 CI 34.0 / 34.7 SE 0.169 |
21.6 CI 21.3 / 21.8 SE 0.132 |
18-24 years |
8.4 CI 8.1 / 8.8 SE 0.166 |
9.7 CI 9.3 / 10.0 SE 0.179 |
16.9 CI 16.4 / 17.4 SE 0.237 |
18.3 CI 17.8 / 18.8 SE 0.247 |
15.8 CI 15.4 / 16.2 SE 0.225 |
14.1 CI 13.6 / 14.5 SE 0.214 |
8.1 CI 7.7 / 8.4 SE 0.160 |
25-44 years |
20.3 CI 20.0 / 20.6 SE 0.153 |
22.8 CI 22.5 / 23.1 SE 0.161 |
34.9 CI 34.5 / 35.3 SE 0.199 |
42.3 CI 41.9 / 42.7 SE 0.218 |
43.3 CI 42.8 / 43.7 SE 0.220 |
41.2 CI 40.8 / 41.6 SE 0.214 |
26.2 CI 25.8 / 26.5 SE 0.169 |
45-64 years |
12.1 CI 11.9 / 12.3 SE 0.120 |
14.6 CI 14.4 / 14.9 SE 0.132 |
22.4 CI 22.0 / 22.7 SE 0.164 |
29.1 CI 28.7 / 29.4 SE 0.187 |
31.8 CI 31.4 / 32.2 SE 0.196 |
32.3 CI 31.9 / 32.7 SE 0.198 |
21.4 CI 21.1 / 21.7 SE 0.161 |
45-54 years |
14.7 CI 14.4 / 15.1 SE 0.188 |
17.3 CI 16.9 / 17.7 SE 0.206 |
26.6 CI 26.1 / 27.1 SE 0.257 |
33.1 CI 32.5 / 33.7 SE 0.285 |
35.6 CI 35.0 / 36.2 SE 0.297 |
35.5 CI 35.0 / 36.1 SE 0.296 |
23.7 CI 23.3 / 24.2 SE 0.241 |
55-64 years |
9.5 CI 9.2 / 9.8 SE 0.150 |
12.0 CI 11.7 / 12.3 SE 0.168 |
18.3 CI 17.9 / 18.8 SE 0.208 |
25.2 CI 24.7 / 25.7 SE 0.243 |
28.1 CI 27.6 / 28.6 SE 0.259 |
29.2 CI 28.7 / 29.7 SE 0.264 |
19.2 CI 18.7 / 19.6 SE 0.214 |
65 years and over |
1.7 CI 1.6 / 1.8 SE 0.056 |
2.1 CI 2.0 / 2.2 SE 0.062 |
3.1 CI 3.0 / 3.3 SE 0.075 |
4.7 CI 4.5 / 4.9 SE 0.092 |
5.8 CI 5.6 / 6.0 SE 0.100 |
6.8 CI 6.6 / 7.0 SE 0.107 |
5.0 CI 4.9 / 5.2 SE 0.091 |
65-74 years |
2.6 CI 2.4 / 2.8 SE 0.092 |
3.3 CI 3.1 / 3.5 SE 0.103 |
5.0 CI 4.7 / 5.2 SE 0.124 |
7.3 CI 7.0 / 7.6 SE 0.147 |
9.2 CI 8.9 / 9.5 SE 0.165 |
10.8 CI 10.4 / 11.1 SE 0.176 |
8.0 CI 7.7 / 8.3 SE 0.150 |
75-84 years |
0.4 CI 0.3 / 0.5 SE 0.051 |
0.5 CI 0.4 / 0.6 SE 0.054 |
0.6 CI 0.5 / 0.8 SE 0.062 |
0.9 CI 0.8 / 1.1 SE 0.075 |
1.2 CI 1.0 / 1.4 SE 0.082 |
1.5 CI 1.3 / 1.7 SE 0.091 |
1.2 CI 1.0 / 1.3 SE 0.078 |
85 years and over |
0.3 CI 0.2 / 0.4 SE 0.065 |
0.2 CI 0.1 / 0.3 SE 0.048 |
0.2 CI 0.1 / 0.4 SE 0.060 |
0.4 CI 0.2 / 0.6 SE 0.078 |
0.2 CI 0.1 / 0.4 SE 0.062 |
0.3 CI 0.2 / 0.5 SE 0.072 |
0.3 CI 0.2 / 0.5 SE 0.071 |
Drug overdose deaths involving synthetic opioids, excluding methadone by Educational attainment (25-64 years), 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Educational attainment (25-64 years) |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Drug overdose deaths involving synthetic opioids, excluding methadone by Family income, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Family income |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Drug overdose deaths involving synthetic opioids, excluding methadone by Health insurance status, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Health insurance status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Drug overdose deaths involving synthetic opioids, excluding methadone by Geographic location, 2018-2024 * 1
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Metropolitan |
10.3 CI 10.2 / 10.5 SE 0.062 |
11.9 CI 11.8 / 12.0 SE 0.067 |
18.3 CI 18.1 / 18.5 SE 0.083 |
22.2 CI 22.1 / 22.4 SE 0.090 |
DNA |
DNA |
DNA |
Non-metropolitan |
7.1 CI 6.8 / 7.4 SE 0.136 |
8.3 CI 8.0 / 8.6 SE 0.147 |
14.3 CI 14.0 / 14.7 SE 0.193 |
19.4 CI 19.0 / 19.9 SE 0.224 |
DNA |
DNA |
DNA |
Drug overdose deaths involving synthetic opioids, excluding methadone by Marital status (25 years and over), 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Marital status (25 years and over) |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Drug overdose deaths involving synthetic opioids, excluding methadone by Country of birth, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Country of birth |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Drug overdose deaths involving synthetic opioids, excluding methadone by Veteran status, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Veteran status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Drug overdose deaths involving synthetic opioids, excluding methadone by Disability status, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Disability status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Drug overdose deaths involving synthetic opioids, excluding methadone by Sexual orientation, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Sexual orientation |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Drug overdose deaths involving synthetic opioids, excluding methadone by Gender identity, 2018-2024 *
(deaths per 100,000 population)
Decrease desired
| Population | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Gender identity |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |